- Open
- 0.27
- High
- 0.27
- Low
- 0.26
- Close
- 0.27
- Change
- -0.01 (-3.70%)
- Volume
- 1,259,529
⌘K
| 8 Apr 2026 | 07:00:09 | Granted U.S. Patent from PTSD Discovery Programme |
| 31 Mar 2026 | 07:00:14 | Granted U.S. Patent from PTSD Discovery Programme |
| 10 Mar 2026 | 07:00:10 | SVN-114 selected for PTSD discovery programme |
| 28 Jan 2026 | 07:00:09 | Expansion of SVN-015 into depression |
| 30 Apr 2025 | Annual Financial Report 31 December 2024 | |
| 14 May 2024 | Annual Financial Report - 31.12.22 |
| 8 Apr 2026 | 07:00:09 | Granted U.S. Patent from PTSD Discovery Programme |
| 31 Mar 2026 | 07:00:14 | Granted U.S. Patent from PTSD Discovery Programme |
| 10 Mar 2026 | 07:00:10 | SVN-114 selected for PTSD discovery programme |
| 28 Jan 2026 | 07:00:09 | Expansion of SVN-015 into depression |
| 30 Apr 2025 | Annual Financial Report 31 December 2024 | |
| 14 May 2024 | Annual Financial Report - 31.12.22 |
| 7 Jan 2026 | 07:00:07 | US Patent allowance for PTSD discovery programme |
| 8 Apr 2026 |
| Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain |
| 8 Apr 2026 | Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain |
| 8 Apr 2026 | Solvonis secures second US patent for PTSD drug programme within a week |
| 31 Mar 2026 | Valereum, Solvonis Therapeutics, RC Fornax, Active Energy, Plexus, Quantum Helium - Small Cap Snapshot |
| 31 Mar 2026 | Solvonis secures US patent for PTSD drug compounds as sector dealmaking intensifies |
| 7 Jan 2026 | 07:00:07 | US Patent allowance for PTSD discovery programme |
| 8 Apr 2026 |
| Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain |
| 8 Apr 2026 | Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain |
| 8 Apr 2026 | Solvonis secures second US patent for PTSD drug programme within a week |
| 31 Mar 2026 | Valereum, Solvonis Therapeutics, RC Fornax, Active Energy, Plexus, Quantum Helium - Small Cap Snapshot |
| 31 Mar 2026 | Solvonis secures US patent for PTSD drug compounds as sector dealmaking intensifies |